Eciruciclib |
| Catalog No.GC64682 |
Eciruciclib is an antineoplastic and potent cyclin dependent kinase (CDK) inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1868086-40-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Eciruciclib is an antineoplastic and potent cyclin dependent kinase (CDK) inhibitor[1].
[1]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
Review for Eciruciclib
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Eciruciclib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *